A novel small molecule inhibitor of hepatitis C virus entry.

A novel small molecule inhibitor of hepatitis C virus entry.

Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects. Resistance to these inhibitors emerges rapidly in the clinic, suggesting that successful...

Full description

Saved in:
Bibliographic Details
Main Authors: Carl J Baldick, Michael J Wichroski, Annapurna Pendri, Ann W Walsh, Jie Fang, Charles E Mazzucco, Kevin A Pokornowski, Ronald E Rose, Betsy J Eggers, Mayla Hsu, Weixu Zhai, Guangzhi Zhai, Samuel W Gerritz, Michael A Poss, Nicholas A Meanwell, Mark I Cockett, Daniel J Tenney
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2010
Subjects:
Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Online Access:https://doaj.org/article/1ee8b0be7b894e5398d932dbcf2e4866
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/1ee8b0be7b894e5398d932dbcf2e4866

Similar Items